Edwards Lifesciences (EW) CFO Theodora Mistras files initial Form 3 report

Rhea-AI Filing Summary

Edwards Lifesciences Corp executive Theodora Mistras, who serves as CVP and Chief Financial Officer, filed an initial Form 3 ownership report. The filing does not list any transactions or derivative positions and serves mainly to identify her role and status as a reporting person for the company.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mistras Theodora

(Last) (First) (Middle)

ONE EDWARDS WAY

(Street)

IRVINE CALIFORNIA 92614

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/29/2026

3. Issuer Name and Ticker or Trading Symbol
Edwards Lifesciences Corp [ EW ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CVP, Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24, Power of Attorney, attached.

No securities are beneficially owned.

	Linda J. Park, Attorney-in-Fact	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Edwards Lifesciences (EW) Form 3 filing by Theodora Mistras show?

The Form 3 shows that Theodora Mistras is a reporting person for Edwards Lifesciences as CVP and Chief Financial Officer. It functions as an initial ownership statement and, in this case, does not report any specific stock or option transactions.

Did Edwards Lifesciences (EW) CFO Theodora Mistras buy or sell shares in this Form 3?

No share purchases or sales are reported in this Form 3 for Theodora Mistras. The transaction summary shows zero buys, zero sells, zero exercises, and no gifts or tax withholdings, indicating no trading activity disclosed in this filing.

Does the Edwards Lifesciences (EW) Form 3 include any derivative securities for the CFO?

The Form 3 derivative summary is empty for Theodora Mistras. That means no stock options, warrants, or other derivative positions are listed in this specific filing, so it focuses only on establishing her as a reporting person.

Is the Edwards Lifesciences (EW) Form 3 for Theodora Mistras a routine filing?

Yes, this Form 3 appears to be a routine initial ownership report for an executive officer. It identifies Theodora Mistras as CVP and Chief Financial Officer and shows no reported transactions or derivative holdings in the data provided.

Does the Edwards Lifesciences (EW) Form 3 indicate that the CFO is a 10% owner?

The Form 3 data indicates that Theodora Mistras is not a ten percent owner of Edwards Lifesciences. She is listed solely as an officer, specifically serving as CVP and Chief Financial Officer, without being flagged as a 10% beneficial owner.